Treatment of Scalp Psoriasis

Rabia Ghafoor, Anant Patil, Paul S. Yamauchi, Jeffrey M. Weinberg, Leon H. Kircik, Stephan Grabbe, Mohamad Goldust

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Scalp involvement is seen in a majority of individuals with psoriasis, a chronic autoimmune skin disease with variable phenotypes. Occasionally, isolated scalp involvement is observed; and this causes significant psychosocial morbidity. Management of scalp psoriasis is difficult, in part due to the difficulty of applying topical agents and its refractory nature. Various treatment options are available with variable efficacy. Topical agents include topical steroids, keratolytics, tar and anthralin compounds, vitamin D analogues, and vitamin A derivatives. The combination treatment of topical betamethasone and calcipotriene is the most effective topical therapy. Systemic agents include conventional agents such as methotrexate, cyclosporine, and oral retinoids. Biologics offer a greater efficacy, with near complete or complete clearance of the scalp. In this article we review the published literature on adult and scalp psoriasis to highlight its treatment. Articles published in peer-reviewed journals were included for qualitative analysis of the literature, including reviews, clinical trials, case series, case reports published in the electronic database (MEDLINE/PubMed) through June 2021, cross references of respective articles, and trials from clinicaltrials.gov.

Original languageEnglish
Pages (from-to)833-837
Number of pages5
JournalJournal of Drugs in Dermatology
Volume21
Issue number8
DOIs
StatePublished - Aug 2022

Fingerprint

Dive into the research topics of 'Treatment of Scalp Psoriasis'. Together they form a unique fingerprint.

Cite this